Stimulation of 5-HT(1A) receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats

British Journal of Pharmacology

Volumn 119, Issue 5, 1996, Pages 813-818

  Gariboldi, Marco ^a   Tutka, Piotr ^a,b   Samanin, Rosario ^a   Vezzani, Annamaria ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b University of Lublin   (Poland)

Author keywords

5 HT(1A) receptors; 8 hydroxy 2 (di n propylamino) tetralin; Anticonvulsants; EEG; Hippocampus; Kainic acid; Limbic seizures; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANTICONVULSIVE AGENT; KAINIC ACID; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; METABOLISM; PATHOPHYSIOLOGY; SEIZURE; SPRAGUE DAWLEY RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; KAINIC ACID; MALE; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0029658235     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15745.x     Document Type: Article

References (43)

1. ARVIDSSON, L.E., HACKSELL, U., NILSSON, J.L.G., HJORTH, S., CARLSSON, A., LINDBERG, P., SANCHEZ, D. & WIKSTROM, H. (1981). 8-Hydroxy-2-(di-n-propylamino) tetralin, a new centrally acting 5-HT receptor agonist. J. Med. Chem., 24, 921-923.
2. AZMITIA, E.C. & SEGAL, M. (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol., 179, 641-668.
3. BASKYS, A., NIESEN, C.E., DAVIES, M.F. & CARLEN, P.L. (1989). Modulatory actions of serotonin on ionic conductances of hippocampal dentate granule cells. Neuroscience, 29, 443-451.
4. BECK, S.G. & CHOI, K.C. (1991). 5-Hydroxytryptamine hyperpolarizes CA3 hippocampal pyramidal cells through an increase in potassium conductance. Neurosci. Lett., 133, 93-96.
5. BEN-ARI, Y. (1985). Limbic seizures and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 14, 375-403.
6. 1A receptors in the dorsal hippocampus impairs acquisition and performance of a spatial task in a water maze. Brain Res., 595, 50-56.
7. 1A receptors. Br. J. Pharmacol., 105, 720-726.
8. 1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Eur. J. Pharmacol., 283, 133-139.
9. CLARK, M., WEISS, S.R.B. & POST, R.M. (1993). Autoradiographic analysis of serotonin receptors and transporter in kindled rat brain. Neurosci. Lett., 161, 21-26.
10. CORRADETTI, R., BALLERINI, L., PUGLIESE, A.M. & PEPEU, G. (1992). Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience, 46, 511-518.
11. DE LA TORRE, J.C., KAWANAGA, H.M. & MULLAN, S. (1970). Seizure susceptibility after manipulation of brain serotonin. Arch. Int. Pharmacodyn., 188, 298-304.
12. ELWES, R.D.S., JOHNSON, A.L., SHORVON, A.D. & REYNOLDS, E.H. (1984). The prognosis for seizure control in newly diagnosed epilepsy. N. Engl. J. Med., 311, 944-947.
13. FAVALE, E., RUBINO, V., MAINARDI, P., LUNARDI, G. & ALBANO, C. (1995). Anticonvulsant effect of fluoxetine in humans. Neurology, 45, 1926-1927.
14. FERKANY, J. & COYLE, J.T. (1983). Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids. J. Pharmacol. Exp. Ther., 225, 399-406.
15. 1A receptor antagonist. Br. J. Pharmacol., 112, 91P.
16. FRENCH, E.D., ALDINIO, C. & SCHWARCZ, R. (1982). Intrahippocampal kainic acid, seizures and local neuronal degeneration: Relationships assessed in unanesthetized rats. Neuroscience, 7, 2525-2536.
17. GHADIMI, B.M. & JAROLIMEK, W. (1994). Effects of serotonin on hilar neurons and granule cell inhibition in the guinea pig hippocampal slice. Brain Res., 633, 27-32.
18. HJORTH, S., CARLSSON, A., LINDBERG, P., SANCHEZ, D., WIKSTROM, H., ARVIDSSON, L.E., HACKSELL, U. & NILSSON, J.L.G. (1982). 8-Hydroxy-2-(di-n-propylamino) tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT receptor stimulating activity. J. Neural Transm., 55, 169-188.
19. INVERNIZZI, R., BELLI, S. & SAMANIN, R. (1992). Citalopram's ability to increase the extracellular concentrations of serotonin in the rat dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res., 584, 322-324.
20. INVERNIZZI, R., BRAMANTE, M. & SAMANIN, R. (1995). Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram. Brain Res., 696, 62-66.
21. KOVACS, D.A. & ZOLL, J.G. (1974). Seizure inhibition by median raphe nucleus stimulation in rat. Brain Res., 70, 165-169.
22. LAZAROVA, M., PRZEWLOCKA, B., MOGILNICKA, E. & STALA, L. (1979). The effect of L-Dopa and L-5-hydroxytryptophan on the pentetrazole seizures in rats after lesions of the median raphe nucleus and substantia nigra. Pol. J. Pharmacol. Pharm., 31, 547-554.
23. LÖSCHER, W. & CZUCZWAR, S.J. (1985). Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy. Neurosci. Lett., 60, 201-206.
24. MACGREGOR, D.G. & STONE, T.W. (1992). Prevention of kainate-induced excitotoxicity by a purine analog. Neuroreport, 3, 536-538.
25. MATTSON, R.H., CRAMER, J.A., COLLINS, J.F., SMITH, D.B., DELGADO-ESCUETA, A.V., BROWNE, T.R. & WILLIAMSON, P.D. (1985). Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N. Engl. J. Med., 313, 145-151.
26. MAURA, G., ROCCATAGLIATA, E., ULIVI, M. & RAITERI, M. (1988). Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors. Eur. J. Pharmacol., 145, 31-38.
27. MCDONALD, J.W. & JOHNSTON, M.V. (1990). Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev., 15, 41-70.
28. 1A receptors: respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochem. Int., 19, 453-465.
29. OLESKEVICH, S. & DESCARRIES, L. (1990). Quantified distribution of the serotonin innervation in adult rat hippocampus. Neuroscience, 34, 19-33.
30. 1A receptor in the rat brain: correlation with receptor binding. J. Neurosci., 12, 440-453.
31. ROPERT, N. (1988). Inhibitory action of serotonin in CA1 hippocampal neurons in vitro. Neuroscience, 26, 69-81.
32. SALGADO, D. & ALKADHI, K.A. (1995). Inhibition of epileptiform activity by serotonin in rat CA1 neurons. Brain Res., 669, 176-182.
33. SCHWARCZ, R. & MELDRUM, B. (1985). Excitatory aminoacid antagonists provide a therapeutic approach to neurological disorders. Lancet, 2, 140-143.
34. SIZER, A.R., KILPATRICK, G.J. & ROBERTS, H.T. (1992). A postsynaptic depressant modulatory action of 5-hydroxytryptamine on excitatory amino acid responses in rat entorhinal cortex in vitro. Neuropharmacology, 31, 531-539.
35. VEZZANI, A., SERAFINI, R., STASI, M.A., VIGANO', G., RIZZI, M. & SAMANIN, R. (1991). A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacology, 30, 345-352.
36. VEZZANI, A., WU, H.Q., TULLII, M. & SAMANIN, R. (1986). Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: Electroencephalographic, behavioral and histological assessments. J. Pharmacol. Exp. Ther., 239, 256-262.
37. WADA, Y., NAKAMURA, M., HASEGAWA, H. & SHIRAISHI, J. (1993a). Microinjection of the serotonin uptake inhibitor fluoxetine elevates hippocampal seizure threshold in rats. Neurosci. Res. Commun., 13, 143-148.
38. WADA, Y., NAKAMURA, M., HASEGAWA, H. & YAMAGUCHI, N. (1993b). Effect of serotonin uptake inhibiting antidepressants on hippocampal kindled seizures in cats. Neurosci. Res. Commun., 12, 119-124.
39. WADA, Y., NAKAMURA, M., HASEGAWA, H. & YAMAGUCHI, N. (1993c). Intra-hippocampal injection of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci. Lett., 159, 179-182.
40. WHITTON, P.S., ORESKOVIC, D., JERNEJ, B. & BULAT, M. (1985). Effect of valproic acid on 5-hydroxytryptamine turnover in mouse brain. J. Pharm. Pharmacol., 37, 199-200.
41. WHITTON, P.S., ORESKOVIC, D., MARKOVIC, Z., SKARPA, D. & BULAT, M. (1983). Effect of the antiepileptic DI-n-propylacetamide on 5-hydroxytryptamine turnover in the brain and 5-hydroxyindoleacetic acid level in the cerebrospinal fluid. Eur. J. Pharmacol., 91, 57-62.
42. YAN, Q.S., JOBE, P.C. & DAILEY, J.W. (1994). Evidence that a serotoninergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur. J. Pharmacol., 252, 105-112.
43. ZHANG, G., FRANKLIN, P.H. & MURRAY, T.F. (1990). Anticonvulsant effect of N-ethylcarboxamidoadenosine against kainic acid-induced behavioral seizures in the rat prepiriform cortex. Neurosci. Lett., 114, 345-350.